| |
Our current coverage
consists of the following companies:
| Company |
Coverage
Date |
Rating* |
Report |
| Allied Capital (ALD) |
7/6/2004 |
Sell |
|
| Antigenics (AGEN) |
5/12/03 |
Buy |
|
| AT Cross (ATX) |
1/7/03 |
Strong Buy |
|
| Cherokee, Inc. (CHKE) |
4/30/04 |
Buy |
|
| Deswell Industries (DSWL) |
1/2/03 |
Buy |
|
| Docucorp International (DOCC) |
10/16/2003 |
Buy |
|
| DOR Biopharma (DOR) |
1/30/03 |
Market Perform |
|
| eMagin Corporation (EMA) |
11/3/03 |
Strong Buy |
|
| Epicor Software (EPIC) |
12/02/03 |
Buy |
EPIC (pdf) |
| GTECH Holdings (GTK) |
7/6/04 |
Buy |
|
| iMergent (IIG) |
12/13/04 |
Buy |
IIG (pdf) |
| Innovo Group (INNO) |
4/21/03 |
Buy |
|
| JDA Software (JDAS) |
5/12/03 |
Market Perform |
|
| KANA Software (KANA) |
1/12/04 |
Strong Buy |
KANA (pdf) |
| KVH Industries (KVHI) |
12/16/02 |
Buy |
|
| Liberty Corporation (LC) |
3/26/03 |
Strong Buy |
|
| Manhattan Associates (MANH) |
5/27/03 |
Market Perform |
|
| NIKU Corp (NIKU) |
09/10/03 |
Strong Buy |
NIKU (pdf) |
| Opsware, Inc. (OPSW) |
06/02/03 |
Strong Buy |
|
| Sybase (SY) |
06/24/03 |
Market Underperform |
|
*The Farmhouse Equity Research, LLC. Rating System
| Strong
Buy |
We
believe that shares of this stock are significantly undervalued
and should be acquired immediately. Over the next 12 months,
we believe that the share price will increase more than 50%
on a sustained basis |
| |
| Buy |
We
believe that shares of this stock are relatively undervalued
and should be acquired on an opportunistic basis. Over
the next 12 months, we believe that the share price will increase
more than 25% on a sustained basis |
| |
| Market
Perform |
We
believe that shares of this stock are fully and fairly valued.
Over the next 12 months, we believe that the share price will
track with the overall market. |
| |
| Market
Underperform |
We
believe that shares of this stock are relatively overvalued
and should be sold on an opportunistic basis. Over the
next 12 months, we believe that the share price will decrease
more than 25% on a sustained basis |
| |
| Sell |
We
believe that shares of this stock are significantly overrvalued
and should be sold or sold short immediately. Over the
next 12 months, we believe that the share price will decrease
more than 50% on a sustained basis |
| |
Disclosure
 Our research does not represent a complete analysis of every material fact regarding any company, industry or security. The opinions expressed by our analysts reflect the judgments of the authors at the date published and are subject to change without notice. Facts have been obtained from sources considered reliable, but are not guaranteed. Farmhouse Equity Research, LLC, its directors and employees and their families are prohibited from having a position in the securities of the companies we cover. Farmhouse Equity Research, LLC is an independent research firm and is not affiliated with any investment bank. Farmhouse Equity Research, LLC does not act as placement agent for securities for which it has research coverage, and we do not attempt to raise capital for companies. Farmhouse Equity materials, including our logo and trademark, are copyrighted; reproduction or redistribution of our reports or other materials, either electronically or via hard copy, without express written permission, is prohibited. Additional information is available upon request.
|
|
